Sentence examples for patent prices from inspiring English sources

In its legal filing on Tuesday, Apple claimed that this strategy was a conspiracy between Nokia and its patent partners, which include Acacia Research and Conversant Intellectual Property Management, to raise patent prices in violation of federal antitrust law.

Thus, while current patent prices may be overly inflated, it is likely that increased prices are here to stay.

Recent lawsuits have driven up patent prices, but a ruling last month against one of Kodak's key innovations may cause uncertainty about its portfolio.

Potential acquirers viewing target companies as part of their risk mitigation strategy should result in increased patent prices being reflected in smaller patent deals, as well as in increased valuations for startup companies with IP holdings.

"While in the short run Nortel's creditors and Motorola's shareholders may have benefitted from patent price inflation, the overall impact will be significant market distortion".

However, there is some concern that the patent price is used to achieve 'super-normal' profits (profits in excess of those required to recoup R&D costs) at the detriment of wider access to patented products [ 2].

Motivated in part by science and in part by the need to create new markets, joint makers churn out new designs that are patented, priced higher and introduced with free training courses for surgeons.

Empirical evidence directly linking patented price and access is rare.

The marketing strategy also differs among pharmaceutical companies, who often spend more heavily on the intensity of advertising once the patent has expired, which could explain at least some of the post-patent price increase.

Papers were categorised into: (i) role of patent on price, (ii) role of patented price on present access, (iii) role of patented price on future access, and (iv) role of patent on international trade and investment.

Patent protected prices cause us to have insurance companies that must decide on complex payment systems and the new industry of pharmacy benefit managers that negotiate directly with the drug companies for both insurance companies and hospitals.